These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37454300)

  • 1. Risk of pneumonia associated with proton pump inhibitor use.
    Watanabe K; Iijima K
    J Gastroenterol; 2023 Sep; 58(9):945-946. PubMed ID: 37454300
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
    Song TJ; Kim J
    PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study.
    Bateman BT; Bykov K; Choudhry NK; Schneeweiss S; Gagne JJ; Polinski JM; Franklin JM; Doherty M; Fischer MA; Rassen JA
    BMJ; 2013 Sep; 347():f5416. PubMed ID: 24052582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nosocomial pneumonia during stress ulcer prophylaxis? - risk of nosocomial pneumonia is increased during stress ulcer prophylaxis].
    Madisch A
    Dtsch Med Wochenschr; 2013 Nov; 138(47):2398. PubMed ID: 24221973
    [No Abstract]   [Full Text] [Related]  

  • 5. Proton pump inhibitor side effects and drug interactions: much ado about nothing?
    Madanick RD
    Cleve Clin J Med; 2011 Jan; 78(1):39-49. PubMed ID: 21199906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia.
    Johnstone J; Nerenberg K; Loeb M
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1165-77. PubMed ID: 20222914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
    Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
    Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term use of proton pump inhibitors--really harmless?].
    Haag S
    Dtsch Med Wochenschr; 2013 Nov; 138(45):2319-21. PubMed ID: 24163169
    [No Abstract]   [Full Text] [Related]  

  • 9. Proton-Pump Inhibitors and Long-Term Risk of Community-Acquired Pneumonia in Older Adults.
    Zirk-Sadowski J; Masoli JA; Delgado J; Hamilton W; Strain WD; Henley W; Melzer D; Ble A
    J Am Geriatr Soc; 2018 Jul; 66(7):1332-1338. PubMed ID: 29676433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit.
    Song MJ; Kim S; Boo D; Park C; Yoo S; Yoon HI; Cho YJ
    Sci Rep; 2021 Sep; 11(1):18467. PubMed ID: 34531488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-acquired pneumonia and acid-suppressive drugs: position statement.
    CAG Clinical Affairs Committee
    Can J Gastroenterol; 2006 Feb; 20(2):119-21, 123-5. PubMed ID: 16482239
    [No Abstract]   [Full Text] [Related]  

  • 12. Proton pump inhibitors: bacterial pneumonia.
    Prescrire Int; 2012 Sep; 21(130):210-2. PubMed ID: 23016253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
    Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
    Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):792-802. PubMed ID: 20623507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-acquired pneumonia and use of gastric acid-suppressive drugs.
    Sataloff RT
    JAMA; 2005 Feb; 293(7):795-6; author reply 796. PubMed ID: 15713765
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse effects of long-term proton pump inhibitor therapy.
    Sheen E; Triadafilopoulos G
    Dig Dis Sci; 2011 Apr; 56(4):931-50. PubMed ID: 21365243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does treating gastroesophageal reflux cause pneumonia?
    Federico M
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):386-7. PubMed ID: 15735501
    [No Abstract]   [Full Text] [Related]  

  • 18. Acid suppression and pneumonia: a clinical indication for rational prescribing.
    Gregor JC
    JAMA; 2004 Oct; 292(16):2012-3. PubMed ID: 15507589
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis.
    Eom CS; Jeon CY; Lim JW; Cho EG; Park SM; Lee KS
    CMAJ; 2011 Feb; 183(3):310-9. PubMed ID: 21173070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.
    Toews I; George AT; Peter JV; Kirubakaran R; Fontes LES; Ezekiel JPB; Meerpohl JJ
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD008687. PubMed ID: 29862492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.